Home » Topics » BioWorld Science

BioWorld Science
RSS

Interim data support continuation of clinical trial testing MEI Pharma's ME-344

Feb. 14, 2018

Researchers develop Drosophila model of multiple sulfatase deficiency

Feb. 14, 2018

Advaxis submits conditional MAA for axalimogene filolisbac in E.U.

Feb. 14, 2018

Study predicts human doses of RVT-801 for treating Farber disease

Feb. 14, 2018

First patient treated in phase I study of NantKwest's HER2.taNK

Feb. 14, 2018

CureVac receives two new grants from the Bill & Melinda Gates Foundation

Feb. 14, 2018

Phase I study begins of AB-569 for antibiotic-resistant bacterial lung infections

Feb. 14, 2018

Novel mutation in GLA gene identified for Fabry disease

Feb. 14, 2018

Pain Therapeutics resubmits Remoxy ER NDA

Feb. 14, 2018

Alkahest obtains grant to develop new Parkinson's disease treatment

Feb. 14, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...